Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heartburn”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Post-approval studies (Phase 4)Study completedNCT00206024
What this trial is testing

Acid-Associated Heartburn Symptoms and Dose of Esomeprazole

Who this might be right for
Heartburn
AstraZeneca 330
Not applicableUnknownNCT05901740
What this trial is testing

Prevalence of Fuctional Heartburn in Patients With IBS .

Who this might be right for
Heartburn
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00701259
What this trial is testing

Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn

Who this might be right for
Frequent Heartburn
Novartis 852
Large-scale testing (Phase 3)Looking for participantsNCT01696734
What this trial is testing

Domperidone in Treating Patients With Gastrointestinal Disorders

Who this might be right for
Digestive System DisorderDyspepsiaEsophagitis+4 more
M.D. Anderson Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT06217393
What this trial is testing

Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia

Who this might be right for
Functional Dyspepsia
Abbott 564
Large-scale testing (Phase 3)Study completedNCT00553449
What this trial is testing

Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.

Who this might be right for
Gastroesophageal RefluxHeartburn
Janssen-Ortho Inc., Canada 48
Not applicableStudy completedNCT01286194
What this trial is testing

Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms

Who this might be right for
Frequent Heartburn
Eisai Inc. 1,500
Not applicableUnknownNCT06214091
What this trial is testing

Gastrointestinal Decompression in Stroke

Who this might be right for
StrokeStomach AcidityPulmonary Infection+1 more
Tianjin Medical University General Hospital 60
Not applicableUnknownNCT05162079
What this trial is testing

Protocol for the ESREFLUJO Study: Epidemiological Study of Heartburn and Gastroesophageal Reflux in Community Pharmacy

Who this might be right for
Reflux
Universidad Miguel Hernandez de Elche 1,200
Post-approval studies (Phase 4)Study completedNCT00701129
What this trial is testing

An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease

Who this might be right for
Pompe DiseaseGlycogen Storage Disease Type II
Genzyme, a Sanofi Company 4
Early research (Phase 1)Study completedNCT01149395
What this trial is testing

Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn

Who this might be right for
HeartburnGastroesophageal Reflux Disease
University of North Carolina, Chapel Hill 40
Testing effectiveness (Phase 2)Study completedNCT01005251
What this trial is testing

Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI

Who this might be right for
Gastroesophageal Reflux DiseaseHeartburnRegurgitation
AstraZeneca 661
Not applicableEnded earlyNCT00576992
What this trial is testing

Demographics and Findings of Upper Endoscopy Patients

Who this might be right for
Barrett EsophagusGastroesophageal Reflux
Midwest Biomedical Research Foundation 1,177
Post-approval studies (Phase 4)Study completedNCT03238534
What this trial is testing

Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

Who this might be right for
GERDEPS
Aboca Spa Societa' Agricola 275
Not applicableStudy completedNCT01647958
What this trial is testing

The EndoGastric Solutions TEMPO Trial

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
EndoGastric Solutions 65
Post-approval studies (Phase 4)Study completedNCT00318084
What this trial is testing

PPI Test in GP Patients

Who this might be right for
GERD
AstraZeneca 100
Large-scale testing (Phase 3)Study completedNCT00627016
What this trial is testing

Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Who this might be right for
Gastroesophageal Reflux
Takeda 305
Post-approval studies (Phase 4)UnknownNCT02277886
What this trial is testing

Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances

Who this might be right for
Gastroesophageal Reflux DiseaseHeartburnSleep Disturbance
Chang Gung Memorial Hospital 340
Not applicableStudy completedNCT01797939
What this trial is testing

Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients

Who this might be right for
Erosive Reflux DiseaseNon-erosive Reflux DiseaseFunctional Heartburn
Seoul National University Bundang Hospital 197
Large-scale testing (Phase 3)Study completedNCT05195528
What this trial is testing

Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Who this might be right for
Non-Erosive Gastro-Esophageal Reflux DiseaseHeartburn
Phathom Pharmaceuticals, Inc. 776
Load More Results